Frischer Lab

Frischer Lab

     
     
    • Frischer Lab Research

      The lab studies angiogenesis which is the formation of new vessels from preexisting vasculature which is pathologic in cancer and chronic inflammation.

      • Ewing’s Sarcoma model and neuroblastoma with EGFR Inhibition to Suppress Vascular Proliferation.
      • The Pathogenesis of inflammatory bowel disease IBD which includes both ulcerative colitis and Crohn’s disease.
    • Publications

      Show All

      2012

      Chernoguz A, Crawford, K, Vandersall A, Willson T, Denson LA, Frischer JS.Pre-treatment with Anti-VEGF therapy may exacerbate inflammation in experimental acute colitis. J Pediatr Surg. 2012 Feb;47(2):347-54.

      Chernoguz A, Crawford KM, Donovan EC, Vandersall AE, Berglund C, Cripe TP, Frischer JS. EGFR Inhibition Fails to Suppress Vascular Proliferation and Tumor Growth in a Ewing’s Sarcoma Model. J Surg Res. 2012 Mar;173(1):1-9.


     
    • Contact Us

      Jason Frischer's headshot photo.

      Jason S. Frischer, MD

      Director, Extracorporeal Membrane Oxygenation Program
      Assistant Professor of Surgery and Pediatrics
      University of Cincinnati College of Medicine
      Division of Pediatric General and Thoracic Surgery
      Cincinnati Children’s Hospital Medical Center

      Phone: 513-636-4371
      Fax: 513-636-7657
      Email: jason.frischer@cchmc.org